» Articles » PMID: 36615698

A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation

Overview
Journal Nutrients
Date 2023 Jan 8
PMID 36615698
Authors
Affiliations
Soon will be listed here.
Abstract

Non-alcoholic fatty liver disease (NAFLD) begins with lipid accumulation within hepatocytes, but the relative contributions of different macronutrients is still unclear. We investigated the impact of fatty acids, glucose and fructose on lipid accumulation in primary human hepatocytes (PHH) and three different cell lines: HepG2 (human hepatoblastoma−derived cell line), Huh7 (human hepatocellular carcinoma cell line) and McA-RH7777 (McA, rat hepatocellular carcinoma cell line). Cells were treated for 48 h with fatty acids (0 or 200 μM), glucose (5 mM or 11 mM) and fructose (0 mM, 2 mM or 8 mM). Lipid accumulation was measured via Nile Red staining. All cell types accumulated lipid in response to fatty acids (p < 0.001). PHH and McA, but not HepG2 or Huh7 cells, accumulated more lipid with 11 mM glucose plus fatty acids (p = 0.004, fatty acid × glucose interaction, for both), but only PHH increased lipid accumulation in response to fructose (p < 0.001). Considerable variation was observed between PHH cells from different individuals. Lipid accumulation in PHH was increased by insulin (p = 0.003) with inter-individual variability. Similarly, insulin increased lipid accumulation in both HepG2 and McA cells, with a bigger response in McA in the presence of fatty acids (p < 0.001 for fatty acid × insulin). McA were more insulin sensitive than either HepG2 or Huh7 cells in terms of AKT phosphorylation (p < 0.001 insulin × cell type interaction). Hence, glucose and fructose can contribute to the accumulation of lipid in PHH with considerable inter-individual variation, but hepatoma cell lines are not good models of PHH.

Citing Articles

Sexually Dimorphic Effects of CYP2B6 in the Development of Fasting-Mediated Steatosis in Mice: Role of the Oxylipin Products 9-HODE and 9-HOTrE.

Eccles-Miller J, Johnson T, Baldwin W Biomedicines. 2025; 13(2).

PMID: 40002708 PMC: 11853041. DOI: 10.3390/biomedicines13020295.


Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans.

Srnic N, Westcott F, Caney E, Hodson L Dis Model Mech. 2025; 18(1).

PMID: 39878508 PMC: 11810042. DOI: 10.1242/dmm.050878.


Fanlian Huazhuo Formula: A promising herbal preparation for metabolic liver disease.

Singla B World J Gastroenterol. 2024; 30(46):4964-4968.

PMID: 39679304 PMC: 11612710. DOI: 10.3748/wjg.v30.i46.4964.


RNA-Sequencing Identification of Genes Supporting HepG2 as a Model Cell Line for Hepatocellular Carcinoma or Hepatocytes.

Stancl P, Grskovic P, Drzaic S, Vicic A, Karlic R, Korac P Genes (Basel). 2024; 15(11).

PMID: 39596661 PMC: 11593409. DOI: 10.3390/genes15111460.


Subcellular expression of CYP2E1 in HepG2 cells impacts response to free oleic and palmitic acid.

Killingsworth Z, Misare K, Ryan A, Ampolini E, Mendenhall T, Engevik M Curr Res Toxicol. 2024; 7:100195.

PMID: 39429948 PMC: 11489078. DOI: 10.1016/j.crtox.2024.100195.


References
1.
Thrift R, Forte T, Cahoon B, SHORE V . Characterization of lipoproteins produced by the human liver cell line, Hep G2, under defined conditions. J Lipid Res. 1986; 27(3):236-50. View

2.
Zhao L, Guo X, Wang O, Zhang H, Wang Y, Zhou F . Fructose and glucose combined with free fatty acids induce metabolic disorders in HepG2 cell: A new model to study the impacts of high-fructose/sucrose and high-fat diets in vitro. Mol Nutr Food Res. 2016; 60(4):909-21. DOI: 10.1002/mnfr.201500635. View

3.
Muriel P, Lopez-Sanchez P, Ramos-Tovar E . Fructose and the Liver. Int J Mol Sci. 2021; 22(13). PMC: 8267750. DOI: 10.3390/ijms22136969. View

4.
Brameld J, Gilmour R, Buttery P . Glucose and amino acids interact with hormones to control expression of insulin-like growth factor-I and growth hormone receptor mRNA in cultured pig hepatocytes. J Nutr. 1999; 129(7):1298-306. DOI: 10.1093/jn/129.7.1298. View

5.
Hoang N, Richter F, Schubert M, Lorkowski S, Klotz L, Steinbrenner H . Differential capability of metabolic substrates to promote hepatocellular lipid accumulation. Eur J Nutr. 2018; 58(8):3023-3034. DOI: 10.1007/s00394-018-1847-2. View